BCM
CC icon

Brightline Capital Management’s Chemours CC Stock Holding History

Brightline Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-465,000
Closed -$15.6M – 10
2021
Q4 		$15.6M Hold
465,000
– – 9.58% 5
2021
Q3 		$13.5M Hold
465,000
– – 9.67% 7
2021
Q2 		$16.2M Hold
465,000
– – 10.89% 3
2021
Q1 		$13M Hold
465,000
– – 8.76% 5
2020
Q4 		$11.5M Hold
465,000
– – 8.7% 4
2020
Q3 		$9.72M Buy
465,000
+135,000
+41% +$2.61M 11.8% 3
2020
Q2 		$5.07M Buy
+330,000
New +$4.17M 19.17% 3

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brightline Capital Management's CC Position: Q1 2022 in Review

Brightline Capital Management sold out of Chemours (CC) in Q1 2022, closing a stake of 465,000 shares — an estimated $15.6M sold.

Brightline Capital Management first reported a position in CC in Q2 2020 and held it in 7 quarters. The position peaked at $16.2M in Q2 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

  • Brightline Capital Management reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
  • Brightline Capital Management sold 465,000 Chemours shares in Q1 2022, an estimated $15.6M.
  • Brightline Capital Management first reported a position in Chemours in Q2 2020 and held it in 7 quarters.
  • Brightline Capital Management's Chemours position peaked at $16.2M in Q2 2021.
  • 481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Brightline Capital Management's 13F filing for Q1 2022, filed 12 May 2022.